Millions Can’t Afford Prescription Medications Due to Their Pricing This is the case for around one in five Americans who cannot afford to purchase required medicines. That is not an embellished claim; it’s the harsh day-to-day stress of millions. The ongoing cost of medications places excessive burdens on families forcing them to dangerously choose between their health and basic household expenses like rent or groceries. In a survey done in 2024, 21% of respondents confessed to not taking, skipping, or delaying medications solely due to the prohibitive costs involved. The…
Read MoreCategory: Health Coverage
Daily articles posted on health insurance changes for all lines of business. Whether you are an agent or a small business owner you will be captivated in how much this industry is changing in the United States today.
Justice, Healthcare, and Humanity on Trial in Mangione Case
Luigi Mangione Pleads Not Guilty to Killing UnitedHealthcare CEO Brian Thompson Luigi Mangione, a 26-year-old Maryland man, has pleaded not guilty to federal murder charges stemming from the December 4, 2024, killing of Brian Thompson, the CEO of UnitedHealthcare. The Mangione case, charged in both federal and state courts, has sparked wide-ranging debates, touching on topics from the state of healthcare to the limits of acceptable dissent. Here’s what we know so far and what the broader implications might mean. The Incident That Shocked a Nation Early that December morning,…
Read MoreLiberty Mutual vs. Mars: Who Picks Up the Tab for Risky Marketing?
Liberty Mutual Drops Lawsuit Against Mars Over Ultra-Processed Food Marketing Case Liberty Mutual Insurance Co. has closed the file on its case against candy giant Mars Inc., leaving questions around insurance coverage for controversial marketing practices unresolved. This voluntary dismissal, filed in the U.S. District Court for the Eastern District of Virginia, has brought an abrupt end to a legal clash that raised eyebrows in both the insurance and food industries. The crux of the matter? Whether Liberty Mutual should have to cover Mars’s legal defense in a lawsuit accusing…
Read MoreHealth Insurance in New Mexico Takes a Step Back on Medical Marijuana Coverage Rights
Federal Judge Ruling on Medical Marijuana Insurance Coverage Debate A landmark ruling has emerged in the ongoing dialogue around medical marijuana, insurance, and federal law. On April 23, 2025, a federal court dismissed a class-action lawsuit that sought to compel insurers in New Mexico to cover medical cannabis as part of behavioral health treatments. The decision, delivered by Judge Martha Vázquez of the U.S. District Court for New Mexico, highlights the deep complexities surrounding the legal status of marijuana and its role in healthcare. Why the Lawsuit Was Filed At…
Read MoreNew York Makes the Cut as the 15th State to Mandate Biomarker Testing Coverage
A Shift Toward Precision Medicine New York has joined the growing ranks of states requiring health insurers to cover biomarker testing, becoming the 15th state to recognize the value of precision medicine. While it may sound like something ripped from a science fiction novel, biomarker testing is a very real, highly effective tool in modern healthcare. It allows doctors to analyze a patient’s tissue, saliva, or blood to identify specific biological markers. These markers help guide decisions on treatments tailored to that individual’s illness, whether it’s cancer, rheumatoid arthritis, or…
Read MoreInsurance Covering Biomarker Testing? Here’s Why New Jersey’s Latest Insurance Law Matters
Biomarker Testing Coverage Now Mandatory for New Jersey Health Insurers New Jersey patients fighting diseases like cancer just gained a significant ally in their treatment plans. Acting Governor Tahesha Way recently signed legislation requiring state-regulated health insurers and Medicaid to cover biomarker testing, ensuring broader access to this crucial diagnostic tool. This advancement promises to make targeted and personalized medicine a reality for thousands across the state. Biomarker testing, for the uninitiated, involves analyzing biological indicators like genes and proteins to provide insights specific to an individual’s condition. It’s often…
Read MoreHow this Healthcare Giant’s Challenges Could Change Insurance as We Know It
UnitedHealth Group Stock Struggles Continue Amid Medicare and ACA Challenges UnitedHealth Group, a giant in the U.S. healthcare industry, has been navigating rough waters lately. You may have noticed headlines about their plummeting stock prices or whispers of trouble in Medicare Advantage plans and Affordable Care Act (ACA) marketplaces. But what does all this mean for you, the average healthcare consumer or investor? Let’s break it down in a way that makes sense without the corporate-speak. UnitedHealth’s Stock Slide Sparks Market Ripples Imagine this for a second. The largest health…
Read More